The global nucleic acid isolation and purification market size was valued at USD 6.33 billion in 2025 and is projected to grow from USD 6.97 billion in 2026 to USD 15.02 billion by 2034, registering a CAGR of 10.08% during the forecast period from 2026 to 2034. North America dominated the nucleic acid isolation and purification market with a market share of 39.5% in 2025.
The nucleic acid isolation and purification market demonstrates steady expansion due to the rising importance of high-fidelity sample preparation in genomics and molecular diagnostics. Demand increases with the shift toward cell-free nucleic acid analysis and multi-omics research that requires precise extraction from complex sample types.
Automation gains traction as laboratories seek reproducible and scalable workflows across decentralized settings. Growth in biologics and gene therapy pipelines strengthens reliance on standardized purification systems. Challenges persist due to sample variability and lack of universal protocols. Opportunities emerge through integrated platforms and sustainable reagent innovations that align with evolving laboratory and regulatory expectations worldwide.
Download a Free Sample To learn more about this report,
Increasing Adoption of Automated Nucleic Acid Extraction and Purification Workflows
The nucleic acid isolation and purification market is increasingly moving toward automated workflows that reduce manual handling, improve extraction consistency, and support higher sample throughput. Automated systems are becoming particularly valuable in molecular diagnostics, genomic testing, research laboratories, and biopharmaceutical applications where laboratories require reproducible DNA and RNA recovery with shorter processing times.
Growing Adoption of Magnetic Bead-Based Nucleic Acid Purification Technologies
Magnetic bead-based purification is gaining adoption because the technology provides efficient DNA and RNA recovery while supporting automation, high-throughput processing, and reproducible workflows. Its compatibility with automated liquid handling systems and closed or semi-closed extraction processes is encouraging laboratories to replace more labor-intensive purification methods with scalable bead-based solutions.
Expansion of Molecular Diagnostics and Genomic Testing Supports Nucleic Acid Isolation Demand
The growing use of PCR, next-generation sequencing, molecular diagnostics, and genomic testing is increasing demand for high-quality DNA and RNA as essential inputs for downstream analysis. Rising testing volumes across infectious disease testing, oncology, genetic disorders, and precision medicine are strengthening the need for reliable isolation and purification workflows that can deliver consistent nucleic acid quality.
High Costs of Automated Extraction Systems Can Limit Adoption
Automated nucleic acid extraction requires investment in instruments, specialized consumables, laboratory infrastructure, maintenance, and workflow integration. These costs can limit adoption among smaller laboratories and research facilities, particularly where sample volumes are insufficient to justify automated systems compared with lower-cost manual or semi-automated extraction methods.
Expansion of Low-Input and Cell-Free Nucleic Acid Applications Creates New Growth Opportunities
The increasing use of low-input DNA and RNA samples in liquid biopsy, circulating cell-free DNA analysis, molecular oncology, and advanced genomic testing is creating opportunities for specialized purification technologies. Extraction solutions capable of recovering high-quality nucleic acids from limited or challenging samples can support more sensitive downstream analysis and expand the addressable applications of purification workflows.
Maintaining Consistent Nucleic Acid Quality Across Complex Sample Types Creates Challenges
Differences in sample composition, inhibitors, degradation, and pre-analytical handling can affect nucleic acid yield and purity across extraction workflows. Difficult matrices such as tissue, formalin-fixed samples, and low-concentration cell-free samples require optimized protocols and effective contaminant removal to produce nucleic acids suitable for sensitive downstream applications.
Automatic Segment is Projected to Register the Fastest Growth at a CAGR of 8.46%
The automatic segment is projected to register the fastest growth at a CAGR of 8.46% during 2026–2034. In 2025, the segment accounted for 17.8% of the global DNA and RNA isolation and purification market, with a value of USD 1.13 billion. Growth is driven by increasing laboratory automation, rising demand for high-throughput sample processing, and the need for accurate and reproducible nucleic acid extraction. Continuous technological advancements and growing adoption of automated laboratory workflows are expected to further support the segment's growth.
The kits & reagents segment dominated the market owing to their recurring use in every DNA and RNA extraction workflow and increasing demand from research, clinical diagnostics, and pharmaceutical laboratories. The instruments segment continues to witness steady demand as laboratories invest in advanced extraction systems to improve operational efficiency. Within this category, manual instruments remain widely used in laboratories with lower testing volumes due to their affordability and operational flexibility.
Request Customizationto receive a tailored report.
RNA Isolation & Purification Segment is Projected to Register the Fastest Growth at a CAGR of 8.53%
The RNA isolation & purification segment is projected to register the fastest growth at a CAGR of 8.53% during 2026–2034. In 2025, the segment accounted for 44.4% of the global DNA and RNA isolation and purification market, with a value of USD 2.81 billion. Growth is driven by increasing genomic and transcriptomic research, expanding applications in molecular diagnostics, and rising demand for RNA-based therapeutics and vaccine development. Advancements in sequencing technologies continue to accelerate the adoption of RNA isolation solutions.
The DNA isolation & purification segment dominated the market owing to its extensive use in genetic research, clinical diagnostics, forensic analysis, and precision medicine. Within this category, genomic DNA isolation & purification accounted for the largest share due to its widespread application in molecular biology and disease research. Plasmid DNA isolation & purification continues to witness steady demand for cloning and recombinant DNA applications, while viral DNA isolation & purification is gaining traction with the increasing focus on infectious disease research and molecular diagnostics.
Within the RNA isolation & purification category, total RNA isolation & purification continues to maintain significant demand because of its broad application in gene expression studies and sequencing workflows. The mRNA isolation & purification and miRNA isolation & purification segments are expanding steadily due to increasing research in transcriptomics, biomarker discovery, and personalized medicine. The other segments include specialized nucleic acid purification techniques that continue to support advanced research and clinical applications.
Magnetic Beads Segment is Projected to Register the Fastest Growth at a CAGR of 9.11%
The magnetic beads segment is projected to register the fastest growth at a CAGR of 9.11% during 2026–2034. In 2025, the segment accounted for 29.8% of the global DNA and RNA isolation and purification market, with a value of USD 1.89 billion. Growth is driven by increasing demand for automated nucleic acid extraction, superior purification efficiency, and compatibility with high-throughput laboratory workflows. Expanding adoption of molecular diagnostics and next-generation sequencing continues to support the segment's growth.
The column-based segment dominated the market owing to its high extraction efficiency, ease of use, and widespread adoption in research and diagnostic laboratories. The reagent-based segment continues to witness steady demand because of its cost-effectiveness and suitability for a broad range of laboratory applications. The others segment includes specialized purification methods that continue to gain adoption for specific research and clinical requirements.
Precision Medicine Segment is Projected to Register the Fastest Growth at a CAGR of 9.42%
The precision medicine segment is projected to register the fastest growth at a CAGR of 9.42% during 2026–2034. In 2025, the segment accounted for 21.4% of the global DNA and RNA isolation and purification market, with a value of USD 1.35 billion. Growth is driven by increasing adoption of personalized healthcare, expanding genomic profiling, and growing use of molecular diagnostics to guide targeted therapies. Continuous advancements in precision medicine and biomarker research are expected to further strengthen the segment's growth.
The diagnostics segment dominated the market owing to the widespread use of nucleic acid isolation technologies in disease detection, infectious disease testing, and genetic screening. The drug discovery & development segment continues to witness strong demand as pharmaceutical and biotechnology companies increasingly rely on high-quality nucleic acid extraction for research and therapeutic development. The agriculture & animal research segment is expanding steadily with the growing application of molecular biology in crop improvement, livestock breeding, and veterinary research.
The other applications segment includes forensic science, environmental monitoring, and various research activities where DNA and RNA isolation technologies continue to support accurate molecular analysis and scientific advancements.
Contract Research Organizations Segment is Projected to Register the Fastest Growth at a CAGR of 8.96%
The contract research organizations segment is projected to register the fastest growth at a CAGR of 8.96% during 2026–2034. In 2025, the segment accounted for 13.6% of the global DNA and RNA isolation and purification market, with a value of USD 0.86 billion. Growth is driven by increasing outsourcing of research activities, expanding clinical trials, and rising demand for specialized molecular biology services. Growing investments in pharmaceutical research and biotechnology development continue to support the segment's expansion.
The pharmaceutical & biotechnology companies segment dominated the market owing to increasing investments in drug discovery, genomics research, and biologics development that require efficient nucleic acid extraction technologies. The academic research institutes segment continues to witness steady demand as universities and research organizations expand studies in molecular biology, genetics, and life sciences. The hospitals and diagnostic centers segment is gaining traction due to the increasing use of molecular diagnostic testing and personalized medicine in clinical practice.
The other end users segment includes government laboratories, forensic laboratories, and environmental testing facilities that continue to adopt DNA and RNA isolation technologies for specialized analytical and research applications.
Speak to an Analystto discuss market opportunities.
North America nucleic acid isolation and purification market accounted for 39.5% of the global market, reaching USD 2.50 billion in 2025, and is projected to grow at a CAGR of 7.85% during the forecast period. The market is driven by increasing demand for molecular diagnostics, rising investments in genomics research, expanding adoption of precision medicine, and strong biotechnology and pharmaceutical research activities. Continuous advancements in automated sample preparation technologies continue to support regional market growth.
The US market was valued at USD 2.13 billion in 2025, making it the largest contributor in North America. Rising adoption of molecular diagnostic technologies, increasing genomic research funding, expanding biotechnology research activities, and growing demand for high-throughput nucleic acid extraction solutions continue to drive market growth.
Canada's market reached USD 0.37 billion in 2025. Growing investments in life sciences research, increasing adoption of automated laboratory technologies, expanding genomics initiatives, and rising demand for reliable nucleic acid purification solutions continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe nucleic acid isolation and purification market accounted for 27.4% of the global market, reaching USD 1.73 billion in 2025, and is projected to grow at a CAGR of 7.62% during the forecast period. Increasing investments in molecular biology research, expanding clinical diagnostics applications, rising adoption of precision medicine, and supportive government funding continue to strengthen regional market growth. Continuous innovation in laboratory automation further supports market expansion.
The UK market was valued at USD 0.35 billion in 2025. Increasing investments in genomic medicine, expanding molecular diagnostic laboratories, growing demand for automated sample preparation systems, and rising research collaborations continue to support market growth.
Germany market accounted for USD 0.48 billion in 2025. Strong biotechnology research capabilities, increasing implementation of advanced nucleic acid extraction technologies, expanding pharmaceutical research activities, and growing investments in precision diagnostics continue to drive market expansion.
Asia Pacific nucleic acid isolation and purification market accounted for 22.6% of the global market, reaching USD 1.43 billion in 2025, and is projected to grow at a CAGR of 9.74% during the forecast period. Rising healthcare expenditure, expanding genomics research, increasing biotechnology investments, and growing adoption of molecular diagnostic technologies continue to accelerate regional market growth. Government initiatives supporting life sciences research further strengthen market expansion.
Japan's market generated USD 0.26 billion in 2025. Increasing adoption of precision medicine, expanding genomic research initiatives, growing demand for advanced molecular diagnostic technologies, and continuous healthcare innovation continue to support market growth.
China's market accounted for USD 0.60 billion in 2025, representing the largest share within Asia Pacific. Expanding biotechnology and pharmaceutical industries, increasing investments in genomic research, growing laboratory automation, and rising demand for high-quality nucleic acid purification technologies continue to drive market expansion.
Latin America nucleic acid isolation and purification market accounted for 6.1% of the global market, reaching USD 0.39 billion in 2025, and is projected to grow at a CAGR of 8.31% during the forecast period. Increasing investments in healthcare infrastructure, expanding molecular diagnostic capabilities, growing awareness of genomic medicine, and rising adoption of advanced laboratory technologies continue to support regional market growth.
Brazil market accounted for USD 0.21 billion in 2025. Rising investments in biotechnology research, increasing implementation of molecular diagnostic platforms, expanding healthcare modernization initiatives, and growing demand for efficient nucleic acid extraction solutions continue to support market expansion.
Middle East & Africa nucleic acid isolation and purification market accounted for 4.4% of the global market, totaling USD 0.28 billion in 2025, and is projected to grow at a CAGR of 7.18% during the forecast period. Increasing investments in healthcare infrastructure, expanding molecular diagnostic laboratories, growing biotechnology research activities, and rising adoption of advanced sample preparation technologies continue to support regional market growth.
The UAE market was valued at USD 0.07 billion in 2025. Increasing investments in genomic medicine, expanding laboratory automation, growing adoption of molecular diagnostics, and rising healthcare modernization initiatives continue to drive market growth.
Africa's market reached USD 0.21 billion in 2025. Improving healthcare infrastructure, increasing access to molecular diagnostic technologies, expanding genomics research initiatives, and growing investments in life sciences continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Bovine Serum Market Size, Share, Growth, Analysis, Report, 2034
Asia Pacific TB Diagnostics Market Size, Share & Growth Graph by 2034
South Korea Epigenetics Market Size, Supply & Growth Report 2034
Europe Tangential Flow Filtration Market Size, Share & Trends | Industry Report, 2034
Asia Pacific Genetic Testing Market Size, 2034
North America TB Diagnostics Market Size & Trends Analysis, 2034
We are featured on:
sales@straitsresearch.com